Clinical Trial Update: S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial investigating everolimus, anastrozole, and fulvestrant in post-menopausal stage IV breast cancer was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Everolimus (everolimus)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer | Phase 3 | Status: TERMINATED | Results posted: 2021-01-28